We have shown that the cytotoxicity of circulating IDO-specific T cells towards IDO-expressing malignant or immune cells was similar between IDO-specific T cells isolated from healthy individuals and those from patients with cancer [40]. The gene discussed is IDO1; the disease is cancer.